-
A QUALITATIVE STUDY TO EXPLORE PATIENT PERSPECTIVES ON FUTURE GENE THERAPY FOR LIMB GIRDLE MUSCULAR DYSTROPHY (LGMD) SARCOGLYCANOPATHY SUBTYPES 2E/R4, 2D/R3, AND 2C/R5
Mar 18, 2026, 21:38 PM -
HARNESSING AGENTIC AI FOR COHORT IDENTIFICATION: A CASE STUDY IN CLL/SLL PATIENTS TREATED WITH BTK INHIBITORS AT A US ACADEMIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
CHARACTERIZING REAL-WORLD DISEASE BURDENS IN CARDIAC AMYLOIDOSIS: A DESCRIPTIVE STUDY ON SOCIAL, ECONOMIC, AND ACCESS-RELATED IMPACTS ON PATIENTS IN GERMANY AND SPAIN
Mar 18, 2026, 21:38 PM -
TRANSLATION AND PSYCHOMETRIC EVALUATION OF THE YORUBA VERSION OF IBADAN LOW-BACK PAIN DISABILITY QUESTIONNAIRE
Mar 18, 2026, 21:38 PM -
CONSENSUS ON BARRIERS AND UNMET NEEDS IN HEMOPHILIA CARE IN BRAZIL: A MODIFIED DELPHI STUDY
Mar 18, 2026, 21:38 PM -
ECONOMIC VALUE OF RSV MATERNAL VACCINATION TO PREVENT INFANT DISEASE IN ECUADOR
Mar 18, 2026, 21:38 PM -
GLOBAL REGULATORY ASYMMETRIES AND THE STRUCTURAL DRUG LAG: TIME TO MARKET AUTHORIZATION IN CÔTE D’IVOIRE
Mar 18, 2026, 21:38 PM -
META-ANALYSIS OF QUALITY OF LIFE AMONG PATIENTS WITH HEPATITIS C WITH OR WITHOUT SUSTAINED VIROLOGICAL RESPONSE
Mar 18, 2026, 21:38 PM -
ALTERNATIVE PAYMENT MODELS IN CARDIOLOGY: A SCOPING REVIEW OF DESIGN FEATURES, QUALITY OUTCOMES, AND COSTS
Mar 18, 2026, 21:38 PM -
COMPARING THE DISEASE BURDEN OF MIGRAINE BETWEEN USERS OF CGRP MONOCLONAL ANTIBODIES AND PREVENTIVE GEPANTS
Mar 18, 2026, 21:38 PM -
ESTIMATING THE FINANCIAL IMPACT OF DUPILUMAB FOR COPD USING REAL-WORLD CLAIMS DATA: A PROBABILISTIC BUDGET IMPACT ANALYSIS IN THE BRAZILIAN PRIVATE HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
FROM PROMPT ENGINEERING TO DECISION-MAKING: ARTIFICIAL INTELLIGENCE IN HEALTH TECHNOLOGY ASSESSMENT
Mar 18, 2026, 21:38 PM -
REAL-WORLD EFFECTIVENESS OF DUPILUMAB IN REDUCING ORAL AND INHALED CORTICOSTEROID USE AMONG US PATIENTS WITH ASTHMA: ANALYSIS FROM THE HEALTHCARE INTEGRATED RESEARCH DATABASE
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS IN COMMERCIALLY INSURED PATIENTS WITH RECURRENT OR PROGRESSIVE ENDOMETRIAL CANCER (EC) IN THE USA
Mar 18, 2026, 21:38 PM -
CONCEPTUAL COST-EFFECTIVENESS FRAMEWORK FOR GMRX2 (TELMISARTAN/AMLODIPINE/INDAPAMIDE) AS EARLY COMBINATION THERAPY FOR US ADULTS WITH HYPERTENSION WITHOUT MAJOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, USED EITHER AT INITIATION OR AS A STEP-UP FROM...
Mar 18, 2026, 21:38 PM -
SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF LATANOPROSTENE BUNOD INITIATORS AMONG MEDICARE FEE-FOR-SERVICE PATIENTS WITH OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION
Mar 18, 2026, 21:38 PM -
GENERAL-PURPOSE VS HEOR-SPECIFIC GENERATIVE AI IN RARE DISEASE MODELING: A DUCHENNE MUSCULAR DYSTROPHY CASE STUDY
Mar 18, 2026, 21:38 PM -
UPDATING SYSTEMATIC LITERATURE REVIEWS AND REPORTS USING A GENERATIVE AI-ENABLED FRAMEWORK
Mar 18, 2026, 21:38 PM -
HOW THE EU JOINT CLINICAL ASSESSMENT UNCERTAINTIES IMPACT US PHARMACEUTICAL MARKET ACCESS
Mar 18, 2026, 21:38 PM -
CAN A GENERATIVE PATIENT JOURNEY FOUNDATION MODEL ALLEVIATE THE BURDEN OF CANCER SCREENING?
Mar 18, 2026, 21:38 PM
